Association of proliferative activity and size in acoustic neuroma: implications for timing of surgery

View More View Less
  • 1 Departments of Otorhinolaryngology and Pathology, University Hospital, School of Medicine, Mainz, Germany; and Department of Otorhinolaryngology, Siriraj University Hospital, School of Medicine, Bangkok, Thailand
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object. Acoustic neuroma is the most frequent benign tumor of the cerebellopontine angle, and surgery is still the most common form of treatment. To gain better insight into the dysregulated mechanisms causing growth of acoustic neuroma, the authors studied the proliferative activity of 34 consecutive samples by analyzing immunohistochemical staining with Ki-67 and proliferating cell nuclear antigen (PCNA), and apoptosis based on the terminal deoxynucleotidyl transferase—mediated deoxyuridine triphosphate nick-end labeling. Data from these analyses were correlated with clinical parameters (that is, tumor size, duration of symptoms, and patient age).

Methods. Apoptotic cells were found in none of the tumors. Proliferation measured on staining with Ki-67 and PCNA correlated with tumor size, but not with patient age or duration of symptoms. The authors demonstrated that tumors 18 mm or smaller in diameter have lower proliferation indices and growth rates, compared with tumors larger than 18 mm with high proliferative indices and growth rates. Additionally, they observed that these more aggressive, larger tumors occur mostly in patients younger than 50 years of age.

Conclusions. Patients with tumors larger than 18 mm in diameter and who are younger than 50 years of age sustain an enhanced risk for fast-growing tumors because of these lesions' enhanced proliferative activity. For these patients the authors recommend active therapy.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Jürgen Brieger, Ph.D., Department of Otorhinolaryngology, University Hospital, School of Medicine, Langenbeckstrasse 1, D-55101 Mainz, Germany. email: Brieger@mail.uni-mainz.de.
  • 1.

    Charabi S, , Engel P, & Charabi B, et al: Growth of vestibular schwannomas: in situ model employing the monoclonal antibody Ki 67 and DNA flow cytometry. Am J Otol 17:301306, 1996 Charabi S, Engel P, Charabi B, et al: Growth of vestibular schwannomas: in situ model employing the monoclonal antibody Ki 67 and DNA flow cytometry. Am J Otol 17:301–306, 1996

    • Search Google Scholar
    • Export Citation
  • 2.

    Charabi S, , Engel P, & Jacobsen GK, et al: Growth rate of acoustic neuroma expressed by Ki-67 nuclear antigen versus symptom duration. Ann Otol Rhinol Laryngol 102:805809, 1993 Charabi S, Engel P, Jacobsen GK, et al: Growth rate of acoustic neuroma expressed by Ki-67 nuclear antigen versus symptom duration. Ann Otol Rhinol Laryngol 102:805–809, 1993

    • Search Google Scholar
    • Export Citation
  • 3.

    Fucci MJ, , Buchman CA, & Brackmann DE, et al: Acoustic tumor growth: implications for treatment choices. Am J Otol 20:495499, 1999 Fucci MJ, Buchman CA, Brackmann DE, et al: Acoustic tumor growth: implications for treatment choices. Am J Otol 20:495–499, 1999

    • Search Google Scholar
    • Export Citation
  • 4.

    Fukuoka S, , Oka K, & Seo Y, et al: Apoptosis following gamma knife radiosurgery in a case of acoustic schwannoma. Stereotact Funct Neurosurg 70:8894, 1998 Fukuoka S, Oka K, Seo Y, et al: Apoptosis following gamma knife radiosurgery in a case of acoustic schwannoma. Stereotact Funct Neurosurg 70:88–94, 1998

    • Search Google Scholar
    • Export Citation
  • 5.

    Garcia RL, , Coltrera MD, & Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134:733739, 1989 Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134:733–739, 1989

    • Search Google Scholar
    • Export Citation
  • 6.

    Gerdes J, , Lemke H, & Baisch H, et al: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antiboby Ki-67. J Immunol 133:17101715, 1984 Gerdes J, Lemke H, Baisch H, et al: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antiboby Ki-67. J Immunol 133:1710–1715, 1984

    • Search Google Scholar
    • Export Citation
  • 7.

    Gerdes J, , Li L, & Schlueter C, et al: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867873, 1991 Gerdes J, Li L, Schlueter C, et al: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867–873, 1991

    • Search Google Scholar
    • Export Citation
  • 8.

    House JW, & Brackmann DE: Facial nerve grading system. Otolaryngol Head Neck Surg 93:146147, 1985 House JW, Brackmann DE: Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147, 1985

    • Search Google Scholar
    • Export Citation
  • 9.

    Jones AS, , Roland NJ, & Caslin AW, et al: A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J Laryngol Otol 108:859864, 1994 Jones AS, Roland NJ, Caslin AW, et al: A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J Laryngol Otol 108:859–864, 1994

    • Search Google Scholar
    • Export Citation
  • 10.

    Kawamoto Y, , Uozumi T, & Kiya K, et al: Clinicopathologic growth factors of acoustic neuromas. Surg Neurol 43:546552, 1995 Kawamoto Y, Uozumi T, Kiya K, et al: Clinicopathologic growth factors of acoustic neuromas. Surg Neurol 43:546–552, 1995

    • Search Google Scholar
    • Export Citation
  • 11.

    Kindblom LG, , Ahlden M, & Meis-Kindblom JM, et al: Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and peripheral nerve sheath tumor. Virchows Arch 427:1926, 1995 Kindblom LG, Ahlden M, Meis-Kindblom JM, et al: Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and peripheral nerve sheath tumor. Virchows Arch 427:19–26, 1995

    • Search Google Scholar
    • Export Citation
  • 12.

    Lesser THJ, , Janzer RC, & Kleihues P, et al: Clinical growth rate of acoustic schwannomas. Correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1:1115, 1991 Lesser THJ, Janzer RC, Kleihues P, et al: Clinical growth rate of acoustic schwannomas. Correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1:11–15, 1991

    • Search Google Scholar
    • Export Citation
  • 13.

    Lörz M, , Meyer-Breiting E, & Bettinger R: Proliferating cell nuclear antigen count as a markers of cell proliferation in head and neck cancer. Eur Arch Otorhinolaryngol 251:9194, 1994 Lörz M, Meyer-Breiting E, Bettinger R: Proliferating cell nuclear antigen count as a markers of cell proliferation in head and neck cancer. Eur Arch Otorhinolaryngol 251:91–94, 1994

    • Search Google Scholar
    • Export Citation
  • 14.

    Prelich G, , Tan CK, & Kostura M, et al: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517520, 1987 Prelich G, Tan CK, Kostura M, et al: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517–520, 1987

    • Search Google Scholar
    • Export Citation
  • 15.

    Rosenberg SI, , Silverstein H, & Gordon MA, et al: A comparison of growth rates of acoustic neuromas: nonsurgical patients vs. subtotal resection. Otolaryngol Head Neck Surg 109:482487, 1993 Rosenberg SI, Silverstein H, Gordon MA, et al: A comparison of growth rates of acoustic neuromas: nonsurgical patients vs. subtotal resection. Otolaryngol Head Neck Surg 109:482–487, 1993

    • Search Google Scholar
    • Export Citation
  • 16.

    Szeremeta W, , Monsell EM, & Rock JP, et al: Proliferation indices of vestibular schwannomas by Ki-67 and proliferating cell nuclear antigen. Am J Otol 16:616619, 1995 Szeremeta W, Monsell EM, Rock JP, et al: Proliferation indices of vestibular schwannomas by Ki-67 and proliferating cell nuclear antigen. Am J Otol 16:616–619, 1995

    • Search Google Scholar
    • Export Citation
  • 17.

    Tos M, , Charabi S, & Thomsen J: Incidence of vestibular schwannomas. Laryngoscope 109:736740, 1999 Tos M, Charabi S, Thomsen J: Incidence of vestibular schwannomas. Laryngoscope 109:736–740, 1999

    • Search Google Scholar
    • Export Citation
  • 18.

    Welkoborsky HJ, , Haibt G, & Mann WJ, et al: Comparison of cytophotometric characteristics to histology and proliferation markers in acoustic neuromas. Ann Otol Rhinol Laryngol 103:4953, 1994 Welkoborsky HJ, Haibt G, Mann WJ, et al: Comparison of cytophotometric characteristics to histology and proliferation markers in acoustic neuromas. Ann Otol Rhinol Laryngol 103:49–53, 1994

    • Search Google Scholar
    • Export Citation
  • 19.

    Wiet RJ, , Ruby SG, & Bauer GP: Proliferating cell nuclear antigen in the determination of growth rates in acoustic neuromas. Am J Otol 15:294298, 1994 Wiet RJ, Ruby SG, Bauer GP: Proliferating cell nuclear antigen in the determination of growth rates in acoustic neuromas. Am J Otol 15:294–298, 1994

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 246 86 3
Full Text Views 128 11 0
PDF Downloads 72 3 0
EPUB Downloads 0 0 0